RxPG News Feed for RxPG News

Medical Research Health Special Topics World
  Home
 
   Health
 Aging
 Asian Health
 Events
 Fitness
 Food & Nutrition
 Happiness
 Men's Health
 Mental Health
 Occupational Health
 Parenting
 Public Health
 Sleep Hygiene
 Women's Health
 
   Healthcare
 Africa
 Australia
 Canada Healthcare
 China Healthcare
 India Healthcare
 New Zealand
 South Africa
 UK
  NHS
 USA
 World Healthcare
 
   Latest Research
 Aging
 Alternative Medicine
 Anaethesia
 Biochemistry
 Biotechnology
 Cancer
 Cardiology
 Clinical Trials
 Cytology
 Dental
 Dermatology
 Embryology
 Endocrinology
 ENT
 Environment
 Epidemiology
 Gastroenterology
 Genetics
 Gynaecology
 Haematology
 Immunology
 Infectious Diseases
 Medicine
 Metabolism
 Microbiology
 Musculoskeletal
 Nephrology
 Neurosciences
 Obstetrics
 Ophthalmology
 Orthopedics
 Paediatrics
 Pathology
 Pharmacology
 Physiology
 Physiotherapy
 Psychiatry
 Radiology
 Rheumatology
 Sports Medicine
 Surgery
 Toxicology
 Urology
 
   Medical News
 Awards & Prizes
 Epidemics
 Launch
 Opinion
 Professionals
 
   Special Topics
 Ethics
 Euthanasia
 Evolution
 Feature
 Odd Medical News
 Climate

Last Updated: Oct 11, 2012 - 10:22:56 PM
Report
UK Channel

subscribe to UK newsletter
Healthcare : UK

   EMAIL   |   PRINT
Nationwide protests in UK against Alzheimer’s drugs decision

Nov 19, 2006 - 9:18:33 AM , Reviewed by: Venkat Yelamanchili
"What sort of society have we become when the health of hundreds of thousands are sold to save just £2.50 a day?"

 
[RxPG]
Nationwide protests in UK against Alzheimer’s drugs decision
The decision to deny life-changing drugs to thousands of people with Alzheimer’s at a saving of just £2.50 a day triggered protest marches across the country on Friday 17th November 2006.

The nationwide action brought together people with Alzheimer’s, carers, doctors and MPs, marching against the recommendation by the National Institute for Health and Clinical Excellence (NICE), to refuse access to treatments for people in the early and late of Alzheimer’s disease on the NHS.

Co-ordinated by the Alzheimer’s Society, more than 30 protests took place across England and Wales, including rallies in London, Manchester, Southampton and Newcastle. Protestors armed with placards, petitions and thousands of signatures met with MPs supporting the Alzheimer’s Society call for doctors to have greater flexibility in prescribing treatments.

Neil Hunt, chief executive of the Alzheimer’s Society, says,

"What sort of society have we become when the health of hundreds of thousands are sold to save just £2.50 a day? This blatant cost cutting will rob people of priceless time early in the disease and later clinicians will have no choice but to use dangerous sedatives that increase the risk of heart disease and stroke. This is victimisation of the most vulnerable in society and today is an opportunity for people to take a stand."

The guidance from NICE comes into force in less than a week, on Wednesday 22 November, despite five appeals and widely acknowledged problems in the appraisal of drug treatments. More than 125 MPs have already signed an Early Day Motion (EDM) demanding action from the Department of Health to make sure doctors continue prescribing treatments in the best interests of their patients.

Celebrities Richard Briers, Fiona Phillips and AA Gill are among those supporting the campaign. Children’s presenter Richard McCourt and Russell Grant led marches in Sheffield and North Wales, with Linda Nolan in Bradford and actress Nicola Duffet supporting the rally in Sutton.

Keith Turner a person with Alzheimer’s disease who took part in a protest in Hastings, said,

"These drugs have given me so much. I used to wander lost and confused but now I can play with my grandchildren, tell my wife I love her and do things for myself again. This is a priceless gift."

Eisai and Pfizer, the manufacturers of one of the drug treatments for Alzheimer's, have informed NICE that they intend to apply for a judicial review against its decision to restrict access to Alzheimer's drugs.

Although the Alzheimer's Society is not involved in this legal action and is seeking legal advice as to whether to launch its own judicial review against the decision in the High Court, our Chief Executive, Neil Hunt welcomed the news.

"It’s great news that NICE will be challenged in court. This has been a flawed process from start to finish. NICE holds the fate of thousands of people’s lives in its hands and it is only right that it is brought to account.

The Alzheimer’s Society has also been seeking separate legal advice as to whether to launch its own judicial review against this decision in the High Court.

NICE’s decision to deny people in the early and late stages of Alzheimer’s disease access to drug treatments is cruel and unethical. That is why thousands of people across the country are taking to the streets today (17 November) to voice their outrage.

This devastating decision was due to come into force next week, surely NICE must now postpone issuing this guidance until all legal challenges have been heard."



Publication: Alzheimer's Society
On the web: Alzheimer's Society Website 

Advertise in this space for $10 per month. Contact us today.


Related UK News


Subscribe to UK Newsletter

Enter your email address:


 Additional information about the news article
The Alzheimer's Society has over 25,000 members and operates through a partnership between over 250 branches and support groups and the national organisation in England, Wales and Northern Ireland. It was founded in 1979 as the Alzheimer's Disease Society.
 Feedback
For any corrections of factual information, to contact the editors or to send any medical news or health news press releases, use feedback form

Top of Page

 
Contact us

RxPG Online

Nerve

 

    Full Text RSS

© All rights reserved by RxPG Medical Solutions Private Limited (India)